8 resultater
The present invention relates in particular to cosmetic and dermatological formulations comprising flavonoids, their glycosides and, if appropriate, combinations thereof with cinnamic acid derivatives or antioxidants.
The damaging effect of the ultraviolet component of solar radiation on the skin is
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to cinnamic acid-based oligomers and therapeutic uses thereof. In particular, the invention provides cinnamic acid-based oligomers, and subsets thereof, for use as anti-coagulants, anti-inflammation agents,
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation application of U.S. patent application Ser. No. 13/926,008 filed Jun. 25, 2013, now U.S. Pat. No. 8,613,909, which was a divisional application of U.S. patent application Ser. No. 13/057,374 filed Sep. 15, 2011, now U.S. Pat.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to cinnamic acid-based oligomers and therapeutic uses thereof. In particular, the invention provides cinnamic acid-based oligomers, and subsets thereof, for use as anti-coagulants, anti-inflammation agents,
This invention relates to a series of cinnamic acid derivatives, to compositions containing them, to processes for their preparation, and to their use in medicine.
Over the last few years it has become increasingly clear that the physical interaction of inflammatory leukocytes with each other and
This invention relates to a series of cinnamic acid derivatives, to compositions containing them, to processes for their preparation, and to their use in medicine.
Over the last few years it has become increasingly clear that the physical interaction of inflammatory leukocytes with each other and
BACKGROUND OF THE INVENTION
The leukotrienes constitute a group of locally acting hormones, produced in living systems from arachidonic acid. The major leukotrienes are Leukotriene B.sub.4 (abbreviated at LTB.sub.4), LTC.sub.4, LTD.sub.4 and LTE.sub.4. The biosynthesis of these leukotrienes begins
BACKGROUND OF THE INVENTION
The leukotrienes constitute a group of locally acting hormones, produced in living systems from arachidonic acid. The major leukotrienes are Leukotriene B.sub.4 (abbreviated as LTB.sub.4), LTC.sub.4, LTD.sub.4, and LTE.sub.4. The biosynthesis of these leukotrienes begins